Allgens Medical Technology CO., LTD. (SHA:688613)
14.77
-0.02 (-0.14%)
Aug 4, 2026, 3:00 PM CST
SHA:688613 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 229.96 | 223.74 | 206.03 | 226.48 | 245.31 | 236.06 |
Revenue Growth | 14.33% | 8.59% | -9.03% | -7.68% | 3.91% | 28.46% |
Gross Profit Gross Profit Growth | 157.34 | 153.45 | 146.63 | 187.24 | 204.51 | 200.44 |
Operating Income Operating Income Growth | 1.18 | -0.53 | -27.44 | 16.02 | 73.91 | 110.28 |
Net Income Net Income Growth | 14.21 | 13.84 | -12.66 | 54.23 | 95.22 | 120.78 |
Earnings Per Share EPS Growth | 0.10 | 0.10 | -0.09 | 0.41 | 0.71 | 1.01 |
EPS Growth | - | - | - | -42.25% | -29.70% | 13.48% |
| Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
Northeast China Northeast China Growth | 14.92 |
North China North China Growth | 31.6 |
East China East China Growth | 109.63 |
Southern China Southern China Growth | 13.06 |
Central China Central China Growth | 19.26 |
Northwestern China Northwestern China Growth | 4.81 |
Southwest China Southwest China Growth | 24.98 |
Overseas Overseas Growth | 0.2 |
Total Total Growth | 218.45 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 1,020 | 1,083 | 1,052 | 1,091 | 1,076 | 1,065 |
Total Debt Total Debt Growth | 15.16 | 47.93 | 52.35 | 53.42 | 61.59 | 80.63 |
Net Cash (Debt) Net Cash Growth | 1,005 | 1,035 | 999.93 | 1,038 | 1,014 | 984.56 |
Net Cash Growth | 1.79% | 3.48% | -3.65% | 2.31% | 3.03% | 133.12% |
Net Cash Per Share Net Cash Per Share Growth | 6.81 | 7.48 | 7.11 | 7.85 | 7.56 | 8.23 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 23.65 | 39.49 | -19.6 | 51.68 | 102.05 | 129.76 |
Capital Expenditures CapEx Growth | -28.9 | -28.93 | -13.43 | -21.9 | -45.42 | -61.22 |
Free Cash Flow Free Cash Flow Growth | -5.25 | 10.56 | -33.03 | 29.78 | 56.63 | 68.54 |
Free Cash Flow Growth | - | - | - | -47.42% | -17.38% | 140.72% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 68.42% | 68.59% | 71.17% | 82.67% | 83.37% | 84.91% |
Operating Margin | 0.51% | -0.24% | -13.32% | 7.07% | 30.13% | 46.72% |
Pretax Margin | 5.92% | 5.49% | -4.34% | 21.68% | 39.22% | 55.94% |
Profit Margin | 6.18% | 6.19% | -6.15% | 23.95% | 38.82% | 51.17% |
FCF Margin | -2.28% | 4.72% | -16.03% | 13.15% | 23.09% | 29.04% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.030 | 0.030 | - | 0.060 | 0.107 | 0.272 |
Dividend Per Share Growth | 0% | - | - | -43.92% | -60.66% | - |
Dividend Yield | 0.20% | 0.15% | - | 0.27% | 0.46% | 0.50% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 153.46 | 201.07 | - | 54.73 | 32.80 | 61.00 |
Forward PE | - | 18.38 | 18.38 | 18.38 | 18.38 | 40.78 |
P/FCF Ratio | - | 263.40 | - | 99.68 | 55.14 | 107.50 |
PS Ratio | 8.80 | 12.44 | 11.87 | 13.11 | 12.73 | 31.21 |